Immune Atlas Articles & Analysis
6 news found
“Unlocking the immune system will accelerate the evaluation and development of novel immune medicines. ...
ByImmunai
AMICA is a downloadable database of annotated multi-omic immune cells that includes information about gene expression, proteins, T-cell and B-cell receptors for immune cells, clinical and/or lab data, and a downloadable artificial intelligence software platform designed for characterizing and analyzing immune cells, as well as analyzing the ...
ByImmunai
Since launching in 2018, the New York City-based company has focused its efforts on multiomic profiling of the immune system and building its Annotated Multiomic Immune Cell Atlas (AMICA). ...
ByImmunai
Now, with February’s series A fundraising—co-led by Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management and Dexcel Pharma, plus backing from Viola Ventures and TLV Partners—Immunai aims to expand its Annotated Multi-omic Immune Cell Atlas, or AMICA, which characterizes individual cells at a high resolution. ...
ByImmunai
Dropprint Genomics, a Y Combinator-backed startup, has developed computational infrastructure to conduct single-cell sequencing at scale, developed proprietary methods for cost-effective processing of hundreds of patient samples, and built a large database of immune cells from autoimmune and cancer cohorts. These cells will be incorporated into Immunai’s Annotated ...
ByImmunai
Immunai will use these funds to expand AMICATM, its proprietary Annotated Multi-omic Immune Cell Atlas, the largest such database in the world. Immunai’s ability to successfully annotate and characterize single cells at high resolution provides the potential for unprecedented insights into the regulation and function of the immune system in ...
ByImmunai